@article {1821,
	title = {Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.},
	journal = {Lancet},
	volume = {360},
	year = {2002},
	month = {2002 Jul 13},
	pages = {119-29},
	abstract = {Insufficient data are available from single cohort studies to allow estimation of the prognosis of HIV-1 infected, treatment-naive patients who start highly active antiretroviral therapy (HAART). The ART Cohort Collaboration, which includes 13 cohort studies from Europe and North America, was established to fill this knowledge gap.},
	keywords = {Adolescent, Adult, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, Europe, Female, HIV Infections, HIV-1, Humans, Male, Middle Aged, Prognosis, Prospective Studies, Risk Factors, Survival Analysis, United States, Viral Load},
	issn = {0140-6736},
	doi = {10.1016/S0140-6736(02)09411-4},
	author = {Egger, Matthias and May, Margaret and Ch{\^e}ne, Genevi{\`e}ve and Phillips, Andrew N and Ledergerber, Bruno and Dabis, Fran{\c c}ois and Costagliola, Dominique and d{\textquoteright}Arminio Monforte, Antonella and de Wolf, Frank and Reiss, Peter and Lundgren, Jens D and Justice, Amy C and Staszewski, Schlomo and Leport, Catherine and Hogg, Robert S and Sabin, Caroline A and Gill, M John and Salzberger, Bernd and Sterne, Jonathan A C}
}
